We have developed an alternative to transgenesis for producing antigen-specific T cells in vivo. In this system, clonal naive T cells with defined antigen specificity are generated by retrovirus-mediated expression of T cell antigen receptor cDNAs in RAG1-deficient murine hematopoietic precursor cells. These T cells can be stimulated to proliferate and produce cytokines by exposure to antigen in vitro, and they become activated and expand in vivo after immunization. IL-2-deficient T cells generated by this technique show decreased proliferation and cytokine production, both of which can be rescued by exogenous addition of this growth factor. Thus, retrovirus-mediated expression of T cell antigen receptor cDNAs in hematopoietic precursor cel...
textThe use of both multipotent progenitors and fully differentiated cells has been demonstrated to ...
Virus-specific T cells (VSTs) are an attractive cell therapy platform for the delivery of tumor-targ...
The promising clinical results obtained with engineered T cells, including chimeric antigen receptor...
We investigated the possibility of introducing exogenous T cell receptor (TCR) genes into T cells by...
Redirecting Ag specificity by transfer of TCR genes into PBLs is an attractive method to generate la...
To broaden the applicability of cellular immunotherapy, adoptive transfer of T-cell receptor (TCR) t...
The diversity of the T cell receptor (TCR) repertoire is limited, because of the processes of positi...
Adoptive transfer of antigen-specific T lymphocytes is an effective form of immunotherapy for persis...
Advances in genetic engineering have made it possible to generate human T cell products that carry d...
Advances in genetic engineering have made it possible to generate human T-cell products that carry d...
The antigen specificity of T lymphocytes is dictated solely by the T cell receptor (TCR) alpha and b...
Recent clinical studies indicate that adoptive T-cell therapy and especially chimeric antigen recept...
Adoptive T cell therapy of renal cell carcinoma (RCC) is limited by the difficulty in generating suf...
The therapeutic efficacy of adoptively transferred cytotoxic T lymphocytes (CTL) has been demonstrat...
Adoptive transfer of antigen-specific T lymphocytes is an attractive form of immunotherapy for haema...
textThe use of both multipotent progenitors and fully differentiated cells has been demonstrated to ...
Virus-specific T cells (VSTs) are an attractive cell therapy platform for the delivery of tumor-targ...
The promising clinical results obtained with engineered T cells, including chimeric antigen receptor...
We investigated the possibility of introducing exogenous T cell receptor (TCR) genes into T cells by...
Redirecting Ag specificity by transfer of TCR genes into PBLs is an attractive method to generate la...
To broaden the applicability of cellular immunotherapy, adoptive transfer of T-cell receptor (TCR) t...
The diversity of the T cell receptor (TCR) repertoire is limited, because of the processes of positi...
Adoptive transfer of antigen-specific T lymphocytes is an effective form of immunotherapy for persis...
Advances in genetic engineering have made it possible to generate human T cell products that carry d...
Advances in genetic engineering have made it possible to generate human T-cell products that carry d...
The antigen specificity of T lymphocytes is dictated solely by the T cell receptor (TCR) alpha and b...
Recent clinical studies indicate that adoptive T-cell therapy and especially chimeric antigen recept...
Adoptive T cell therapy of renal cell carcinoma (RCC) is limited by the difficulty in generating suf...
The therapeutic efficacy of adoptively transferred cytotoxic T lymphocytes (CTL) has been demonstrat...
Adoptive transfer of antigen-specific T lymphocytes is an attractive form of immunotherapy for haema...
textThe use of both multipotent progenitors and fully differentiated cells has been demonstrated to ...
Virus-specific T cells (VSTs) are an attractive cell therapy platform for the delivery of tumor-targ...
The promising clinical results obtained with engineered T cells, including chimeric antigen receptor...